February - 2025

top of page

Subscribe to our newsletter

News

Categories

Sign up

Featured Posts

How Israeli technology saved 78-year-old Leah from skin cancer

How Israeli technology saved 78-year-old Leah from skin cancer

How Israeli technology saved 78-year-old Leah from skin cancer

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment

Archive

Follow Us

Alpha Tau to Participate in March Investor Conferences

Alpha Tau to Participate in March Investor Conferences

Alpha Tau to Participate in March Investor Conferences

JERUSALEM, February 27, 2025 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...

Feb 27, 2025

Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification

Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification

Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification

Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification

Feb 24, 2025

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Coh

Feb 3, 2025

bottom of page